Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Kate J. Fisher"'
Autor:
Eric B. Haura, Kazuhiko Nakagawa, Isamu Okamoto, Takafumi Okabe, Kiyoko Shibata, Haruka Yamaguchi, Yume Morita, Michiko Kitano, Ann Y. Chen, Kate J. Fisher, Bhupendra Rawal, John Koomen, Bin Fang, Jiannong Li, Yun Bai, Alex S. Lopez, Matthew A. Smith, Guolin Zhang, Takeshi Yoshida
PDF file - 95KB, Supplementary Table S3-A. Human tumor pY proteome. S3-B. Comparison analysis of unique pTyr sites iden_fy from di_erent samples.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::991bcc4786a7c4e9ccf717b3412d1ebc
https://doi.org/10.1158/1078-0432.22451522
https://doi.org/10.1158/1078-0432.22451522
Autor:
Eric B. Haura, Kazuhiko Nakagawa, Isamu Okamoto, Takafumi Okabe, Kiyoko Shibata, Haruka Yamaguchi, Yume Morita, Michiko Kitano, Ann Y. Chen, Kate J. Fisher, Bhupendra Rawal, John Koomen, Bin Fang, Jiannong Li, Yun Bai, Alex S. Lopez, Matthew A. Smith, Guolin Zhang, Takeshi Yoshida
PDF file - 104KB, Supplementary Figure 1A-B: PC9GR cells acquired drug resistance to both reversible and irreversible EGFR-TKI. A: PC9 and PC9GR cells were treated for 72 h with increasing concentrations of erlotinib or CL387,785. Data generated by c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07edd3d5fa6425e9291123271d8df6e8
https://doi.org/10.1158/1078-0432.22451540
https://doi.org/10.1158/1078-0432.22451540
Autor:
Eric B. Haura, Kazuhiko Nakagawa, Isamu Okamoto, Takafumi Okabe, Kiyoko Shibata, Haruka Yamaguchi, Yume Morita, Michiko Kitano, Ann Y. Chen, Kate J. Fisher, Bhupendra Rawal, John Koomen, Bin Fang, Jiannong Li, Yun Bai, Alex S. Lopez, Matthew A. Smith, Guolin Zhang, Takeshi Yoshida
PDF file - 139KB, Effects of ligands exposure with or without EGFR-TKI in PC9 and PC9GR cells. A-F: PC9 (A, C, and E) or PC9GR cells (B, D, and F) were incubated for 1 hour in the absence or presence of 100 nM erlotinib (A, C, and E) or afatinib (B,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4edeed900b8dc7c11820b71a014e025f
https://doi.org/10.1158/1078-0432.22451531.v1
https://doi.org/10.1158/1078-0432.22451531.v1
Autor:
Eric B. Haura, Kazuhiko Nakagawa, Isamu Okamoto, Takafumi Okabe, Kiyoko Shibata, Haruka Yamaguchi, Yume Morita, Michiko Kitano, Ann Y. Chen, Kate J. Fisher, Bhupendra Rawal, John Koomen, Bin Fang, Jiannong Li, Yun Bai, Alex S. Lopez, Matthew A. Smith, Guolin Zhang, Takeshi Yoshida
PDF file - 54KB, A: Example of peak area (EIC) for EGFR pY 1172. B: Example of peak area (EIC) for MET pY 1234.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c574f49686bb575e00db44016d1abef
https://doi.org/10.1158/1078-0432.22451537
https://doi.org/10.1158/1078-0432.22451537
Autor:
Eric B. Haura, Kazuhiko Nakagawa, Isamu Okamoto, Takafumi Okabe, Kiyoko Shibata, Haruka Yamaguchi, Yume Morita, Michiko Kitano, Ann Y. Chen, Kate J. Fisher, Bhupendra Rawal, John Koomen, Bin Fang, Jiannong Li, Yun Bai, Alex S. Lopez, Matthew A. Smith, Guolin Zhang, Takeshi Yoshida
Purpose: Irreversible EGFR-tyrosine kinase inhibitors (TKI) are thought to be one strategy to overcome EGFR-TKI resistance induced by T790M gatekeeper mutations in non–small cell lung cancer (NSCLC), yet they display limited clinical efficacy. We h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::835d70b5f30c2efd9300b677e85079ab
https://doi.org/10.1158/1078-0432.c.6522212.v1
https://doi.org/10.1158/1078-0432.c.6522212.v1
Autor:
Eric B. Haura, Kazuhiko Nakagawa, Isamu Okamoto, Takafumi Okabe, Kiyoko Shibata, Haruka Yamaguchi, Yume Morita, Michiko Kitano, Ann Y. Chen, Kate J. Fisher, Bhupendra Rawal, John Koomen, Bin Fang, Jiannong Li, Yun Bai, Alex S. Lopez, Matthew A. Smith, Guolin Zhang, Takeshi Yoshida
PDF file - 91KB, A: Effects of dasatinib combined with afatinib on apoptosis in HCC4006-T790M and HCC827-T790M cells. Apoptosis assay was carried out using PE-conjugated caspase-3 antibody, following incubation of HCC4006-T790M or HCC827-T790M cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b47aefa02e467e85264941daffdabd6
https://doi.org/10.1158/1078-0432.22451528.v1
https://doi.org/10.1158/1078-0432.22451528.v1
Autor:
Eric B. Haura, Kazuhiko Nakagawa, Isamu Okamoto, Takafumi Okabe, Kiyoko Shibata, Haruka Yamaguchi, Yume Morita, Michiko Kitano, Ann Y. Chen, Kate J. Fisher, Bhupendra Rawal, John Koomen, Bin Fang, Jiannong Li, Yun Bai, Alex S. Lopez, Matthew A. Smith, Guolin Zhang, Takeshi Yoshida
PDF file - 387KB, Effects of ligands exposure with or without EGFR-TKI in PC9 and PC9GR cells. A-F: PC9 (A, C, and E) or PC9GR cells (B, D, and F) were incubated for 1 hour in the absence or presence of 100 nM erlotinib (A, C, and E) or afatinib (B,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b18545516cdebd51632b4a13a8f8560
https://doi.org/10.1158/1078-0432.22451534
https://doi.org/10.1158/1078-0432.22451534
Autor:
Eric B. Haura, Kazuhiko Nakagawa, Isamu Okamoto, Takafumi Okabe, Kiyoko Shibata, Haruka Yamaguchi, Yume Morita, Michiko Kitano, Ann Y. Chen, Kate J. Fisher, Bhupendra Rawal, John Koomen, Bin Fang, Jiannong Li, Yun Bai, Alex S. Lopez, Matthew A. Smith, Guolin Zhang, Takeshi Yoshida
PDF file - 67KB, Supplementary Table S1: Quantitation of pY changes in between PC9 and PC9GR cell lines with and without erlotinib treatment. The cutoff was set as P value1.5; Supplementary Table S2: Cell viability IC50 in PC9GR cells and H1975 cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68eee20fe3ec64e40297cc6fc2ff0c28
https://doi.org/10.1158/1078-0432.22451519.v1
https://doi.org/10.1158/1078-0432.22451519.v1
Autor:
Shalaka S Hampras, Anna R Giuliano, Hui-Yi Lin, Kate J Fisher, Martha E Abrahamsen, Bradley A Sirak, Michelle R Iannacone, Tarik Gheit, Massimo Tommasino, Dana E Rollison
Publikováno v:
PLoS ONE, Vol 9, Iss 9, p e104843 (2014)
Accumulating evidence suggests that cutaneous human papillomavirus (HPV) infection is associated with non-melanoma skin cancer (NMSC). Little is known about the natural history of cutaneous HPV. A sub-cohort of 209 men with no NMSC history, initially
Externí odkaz:
https://doaj.org/article/e7ea109715204572b78a70a466bcda1f
Autor:
Kate J, Fisher, Ji-Hyun, Lee, Jeanne M, Ferrante, Ellen P, McCarthy, Eduardo C, Gonzalez, Ren, Chen, Kymia, Love-Jackson, Richard G, Roetzheim
Publikováno v:
Cancer. 119(16)
Primary care physician (PCP) services may have an impact on breast cancer mortality and incidence, possibly through greater use of screening mammography.The authors conducted a retrospective, 1:1 matching case-control study using the Surveillance, Ep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7c96c524414d30491798ba622886c067
https://pubmed.ncbi.nlm.nih.gov/23677482
https://pubmed.ncbi.nlm.nih.gov/23677482